Global Non-Small Cell Lung Cancer Diagnostics Market to 2032

Overview

The Global Non-Small Cell Lung Cancer Diagnostics Market is expected to reach a 5.68 USD Billion by 2032 and is projected to grow at a CAGR of 21.47% from 2025 to 2032.

Revenue, 2024 (USD Billion)

2.09

Forecast, 2032 (USD Billion)

5.68

CAGR, 2024 - 2032

21.47%

Report Coverage

Global

Global Non-Small Cell Lung Cancer Diagnostics Market 2018-2032 USD Billion

Global Non-Small Cell Lung Cancer Diagnostics Market, Key Findings (2025-2032)

Market Growth and Projections:

Market Size (2024): 2.09 USD Billion
Projected Market Size (2032): 5.68 USD Billion
CAGR (2025-2032): 21.47%

Key Findings of Global Non-Small Cell Lung Cancer Diagnostics Market

The Global Non-Small Cell Lung Cancer Diagnostics Market was valued at 2.09 USD Billion in 2024.
The Global Non-Small Cell Lung Cancer Diagnostics Market is likely to grow at a CAGR of 21.47% during the forecast period of 2024 to 2032.
In 2024, the Largest segment Lung Adenocarcinoma (LUAD) in Lung Cancer Type Segment accounted for the largest share of the market with a revenue of 1.08 USD Billion
The fastest growing segment Imaging Test in Test Segment grew Fastest with a CAGR of 24.48% during the forecast period from 2024 to 2032.

Global Non-Small Cell Lung Cancer Diagnostics Market Scope

Global Non-Small Cell Lung Cancer Diagnostics Market Segmentation & Scope

Test

Thorecentesis
Sputum Cytology
Biopsy
Others
Immunohistochemistry
Imaging Test
Molecular Test

End User

Institutes and Research Centers
Academics
Hospital
Clinical Laboratories

Lung Cancer Type

Others
Large Cell Carcinoma
Lung Squamous CellCarcinoma (LUSC)
Lung Adenocarcinoma (LUAD)

Product

Services and Softwares
Reagents and Kits
Instruments

Global Non-Small Cell Lung Cancer Diagnostics Market Data Coverage Insights

Study Period	2024-2032
Base Year	2020
Unit	Revenue in USD Billion
Market Value in 2024	2.09 USD Billion
Market Value in 2032	5.68 USD Billion
CAGR (2025-2032)	21.47%
Historic Data	2016-2023
Market Segments Covered	Test,End User,Lung Cancer Type,Product

Regional Insights:

Leading Market (2024-2032): Global, leading in terms of revenue 2.09 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 803.06 USD Million in 2024.

Segments and Scope

Global Non-Small Cell Lung Cancer Diagnostics Market to 2032, By Test
- Molecular Test is the largest segment in Global Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a revenue of 1.07 USD Billion in the year 2024.
- Imaging Test is the Fastest growing segment in Global Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a Growth rate of 21.39 % in forecast period 2025-2032.
Global Non-Small Cell Lung Cancer Diagnostics Market to 2032, By End User
- Clinical Laboratories is the largest segment in Global Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a revenue of 763.96 USD Billion in the year 2024.
- Clinical Laboratories is the Fastest growing segment in Global Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a Growth rate of 22.75 % in forecast period 2025-2032.
Global Non-Small Cell Lung Cancer Diagnostics Market to 2032, By Lung Cancer Type
- Lung Adenocarcinoma (LUAD) is the largest segment in Global Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a revenue of 1.08 USD Billion in the year 2024.
- Lung Adenocarcinoma (LUAD) is the Fastest growing segment in Global Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a Growth rate of 21.89 % in forecast period 2025-2032.
Global Non-Small Cell Lung Cancer Diagnostics Market to 2032, By Product
- Instruments is the largest segment in Global Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a revenue of 941.54 USD Billion in the year 2024.
- Reagents and Kits is the Fastest growing segment in Global Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a Growth rate of 21.00 % in forecast period 2025-2032.

Global Non-Small Cell Lung Cancer Diagnostics Market Company Share Analysis

Company Name
QIAGEN
Quest Diagnostics Incorporated
Abbott
General Electric
F. Hoffmann-La Roche Ltd.

Global Non-Small Cell Lung Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion

Global Non-Small Cell Lung Cancer Diagnostics Market Company Profiling

Industry Related Reports

Global Breast Lesion Localization Methods Market

Global Bone Marrow Biopsy Market

Global Cancer Spit Test Devices Market

Global Gastric Cancer Diagnostics Market

Global Prostate Cancer Diagnostics Market

Global Radiotherapy Market

Global Needle Biopsy Market

Global Proton Therapy Market

Global Cancer Supportive Care Products Market

Global Lung Cancer Screening Software Market

Frequently Asked Questions

What are the primary segments covered in the Global Non-Small Cell Lung Cancer Diagnostics Market?

The Global Non-Small Cell Lung Cancer Diagnostics Market is segmented based on Segmentation Test,End User,Lung Cancer Type,Product.

What is the current market size of the Global Non-Small Cell Lung Cancer Diagnostics Market?

Global Non-Small Cell Lung Cancer Diagnostics Market was valued at USD 2.09(Revenue in USD Billion) in 2020.

What is the expected growth rate of the Global Non-Small Cell Lung Cancer Diagnostics Market?

Global Non-Small Cell Lung Cancer Diagnostics Market is projected to grow at a CAGR of 21.47% during the forecast period of 2024 to 2032.

Which is the dominating segment in the Global Non-Small Cell Lung Cancer Diagnostics Market?

The Lung Adenocarcinoma (LUAD) segment is expected to dominate the Global Non-Small Cell Lung Cancer Diagnostics Market, holding a largest market share of 1.08 USD Billion in 2024